APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
Condition: Hematologic Malignancies Intervention: Drug: APG-2575 Sponsor: Ascentage Pharma Group Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials